Answer
The safety and efficacy of the Aurobindo Pharma - Milpharm Ltd. piperacillin/tazobactam 4 g/0.5 g infusion product have not been established in children under 2 years, and no data from controlled clinical studies are available.
Sources for this answer
- Piperacillin/Tazobactam 4 g / 0.5 g powder for solution for infusionAurobindo Pharma - Milpharm Ltd. · emc · SmPC §4.2 Posology and method of administration · Version 10Document updated
Sources checked